Work out the cost / Briefing
What peptide care costs: read the full bill
Separate care fees, medicine, tests and delivery; understand cash prices, savings terms and the price after an introductory offer.
Quoted drug offers: as of September 26, 2026.
Compare a full month of care
Care fees
Ask whether payment covers a visit, ongoing membership or a prepaid period.
Medicine
Ask whether the medicine is included. A membership can charge for care and leave the medicine as a separate bill.
Tests and delivery
Ask which charges sit outside the headline figure and whether a local test adds another bill.
The price after the offer
Ask for the continuing charge and the terms for ending the service.
Cash prices for weight-care medicines
As of September 26, 2026, cash offers for semaglutide, tirzepatide and orforglipron products mostly ranged from $149 to $499 per month.
These advertised offers depend on the product, strength and refill terms; some late-refill prices are higher.
What an offer calls a “month” varies by medicine: it might supply pens by the box, tablets by the bottle or enough medicine for 28 days. These prices leave out some costs of care.
Price labels mean different things
- List price
A drug maker’s published price differs from both a cash offer and the amount paid through insurance.
- Cash or self-pay price
Cash payment sits outside insurance. It does not count toward the costs your plan makes you pay first or its annual limit on your own spending.
- Copay card
A copay is the patient’s share of an insured bill. Savings cards for branded semaglutide and tirzepatide products require private or workplace insurance and exclude people in government health programs, such as Medicare.
Read the expiry terms
Among the cash offers and savings-card terms checked on September 26, 2026, many have an end date of December 31, 2026.
When that date arrives, the price needs checking again; the date gives no clue to the offer that will follow.
Request a written quote with the first bill and the ongoing bill shown separately.
Reading notes
- CMS: a separate Medicare payment route
The Centers for Medicare & Medicaid Services runs the Medicare GLP-1 Bridge, a temporary program for certain weight-care medicines. People enrolled in Part D who meet its rules pay $50 each month. Ask whoever writes your prescription to review whether you qualify.
- FDA: claims about compounded products
The Food and Drug Administration (FDA) calls it misleading to say that an approved medicine and a compounded product are the same.